Treatment of the neonatal patient with clinically complex wounds creates a challenge due to the safety and efficacy issues associated with the use of many advanced wound care products. The purpose of this case series was to present outcomes of 3 neonates with wounds of differing etiologies managed by Active Leptospermum Honey (ALH).
Clinical case series.
Clinical experiences with 3 neonates, 1 male and 2 females, are described. These premature infants received care at Rush University Medical Center, Houston, Texas, or Driscoll Children's Hospital, Corpus Christi, Texas.
Each neonate presented with dissimilar wounds and differing treatment goals. For a premature infant with left foot ischemia, ALH dressings allowed for removal of nonviable tissue and facilitated the granulation of the open wounds. This removal of nonviable tissue coupled with the facilitation of granulation tissue enabled the premature infant's toe tips to be salvaged without requiring aggressive surgical intervention. For the 2 preterm infants with extravasation of intravenous solutions, ALH dressings allowed healing and increased tissue granulation without any noted toxicity to the wound bed. Further, the method of action of ALH includes an osmotic pull effect that reduced periwound erythema and edema.
Although the use of ALH has been well documented in adult care, these case studies demonstrate its potential use in different wound etiologies in 3 neonatal patients.
Lynn D. Mohr, MS, APN, PCNS-BC, CPN, Instructor, Rush University, Chicago, Illinois.
Roxana Reyna, BSN, RN-NIC, WCC, Registered Nurse, Driscoll Children's Hospital, Corpus Christi, Texas.
Rene Amaya, MD, FAAP, Specialist, Pediatric Infectious Disease, Houston, Texas.
Correspondence: Lynn D. Mohr, MS, APN, PCNS-BC, CPN, Rush University, 600 South Paulina, Suite 1057, AAC Chicago, IL 60612 (Lynn_Mohr@rush.edu; Eeyore101@att.net).
The authors declare no conflict of interest.